Skip to main content

Advertisement

Table 3 Solutions for the cancer vs human problem

From: Predicting and characterizing selective multiple drug treatments for metabolicdiseases and cancer

# Drugs Side effect
1 Floxuridine (# 20) 1
2 Mycophenolic acid (# 42) 4
3 Trimethoprim (# 29) 5
4 Methotrexate (# 11) 5
5 Atovaquone (# 69) 6
6 Tyloxapol (# 85) 6
7 Ezetimibe (# 56) 12
8 Pemetrexed (# 41) 15
9 Ribavirin (# 51) 17
10 Quinacrine (# 36) 22
11 Myo-Inositol (# 82) 29
12 Tioconazole (# 60) 34
13 Naftifine (# 43) 34
14 Simvastatin (# 4) 42
15 Leflunomide (# 66) 42
16 Auranofin (# 59) - Fomepizole (# 75) 47
17 Indomethacin (# 22) 48
18 Diclofenac (# 35) 55
19 Hydroxyurea (# 16) 56
20 Arsenic trioxide (# 72) 56
21 Gemcitabine (# 30) 99
  1. We report the solutions and the side effects σ(D) forthe inhibition with approved drugs. Drug numbers refer to Additional file1: Table S1. Bold font indicates that thesolution has an experimental validation.